(1)
Deepak Sabharwal; Iana Malasevskaia. Role of PCSK9 Inhibitors in Contemporary Lipid-Lowering Era: A Systematic Review of LDL-C Reduction, Cardiovascular Outcomes, and Use in Statin-Intolerant and Very-High-Risk Patients. Journal For International Medical Graduates 2026, 5 (1). https://doi.org/10.56570/hkdzy418.